Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Bladder Cancer

  Free Subscription

Articles published in Eur J Cancer

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    January 2019
  1. ROUANNE M, Betari R, Radulescu C, Goubar A, et al
    Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Eur J Cancer. 2019;108:111-119.
    PubMed     Abstract available

    June 2018
  2. NECCHI A, Raggi D, Giannatempo P, Alessi A, et al
    Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.
    Eur J Cancer. 2018;96:128-130.

    May 2018
  3. CAPURSO G, Archibugi L, Tessieri L, Petrone MC, et al
    Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?
    Eur J Cancer. 2018;95:123-126.

    April 2018
  4. ANDREASSEN BK, Grimsrud TK, Haug ES
    Bladder cancer survival: Women better off in the long run.
    Eur J Cancer. 2018;95:52-58.
    PubMed     Abstract available

    February 2017
    Bladder cancer and smoking with special reference to education.
    Eur J Cancer. 2017;75:1-2.

    October 2016
  6. VAN DER HEIJDEN AG, Mengual L
    Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32449.

  7. ORSOLA A, Mullane SA, Bellmunt J
    Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernandez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32448.

  8. GOOSSENS ME, Zeegers MP, van Poppel H, Joniau S, et al
    Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
    Eur J Cancer. 2016;69:9-18.
    PubMed     Abstract available

  9. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, et al
    Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Eur J Cancer. 2016;69:1-8.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.